Publications of E. B. Binder

Baghai, T. C.; Binder, E. B.; Schule, C.; Salyakina, D.; Eser, D.; Lucae, S.; Zwanzger, P.; Haberger, C.; Zill, P.; Ising, M. et al.; Deiml, T.; Uhr, M.; Illig, T.; Wichmann, H.-E.; Modell, S.; Nothdurfter, C.; Holsboer, F.; Müller-Myhsok, B.; Möller, H.-J.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Molecular Psychiatry 11, pp. 1003 - 1015 (2006)

Binder, E. B.; Holsboer, F.: Pharmacogenomics and antidepressant drugs. Annals of Medicine 38, pp. 82 - 94 (2006)

Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Pütz, B.; Uhr, M.; Binder, E. B.; Holsboer, F.; Keck, M. E.: Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31, pp. 2515 - 2522 (2006)

Himmerich, H.; Binder, E. B.; Künzel, H. E.; Schuld, A.; Lucae, S.; Uhr, M.; Pollmächer, T.; Holsboer, F.; Ising, M.: Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biological Psychiatry 60, pp. 882 - 888 (2006)

Lucae, S.; Salyakina, D.; Barden, N.; Harvey, M.; Gagné, B.; Labbé, M.; Binder, E. B.; Uhr, M.; Paez-Pereda, M.; Sillaber, I. et al.; Ising, M.; Brückl, T.; Lieb, R.; Holsboer, F.; Müller-Myhsok, B.: P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Human Molecular Genetics 15 (16), pp. 2438 - 2445 (2006)

Post, A.; Ackl, N.; Rücker, M.; Schreiber, Y.; Binder, E. B.; Ising, M.; Sonntag, A.; Holsboer, F.; Almeida, O. F.X.: Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-Type dementia versus major depression. Biological Psychiatry 59, pp. 858 - 862 (2006)

Barden, N.; Harvey, M.; Gagne, B.; Raymond, C.; Labbe, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.: A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), p. 82 - 82 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), p. 44 - 44 (2005)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), p. 45 - 45 (2005)

Baghai, T. C.; Binder, E. B.; Holsboer, F.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism. Pharmacopsychiatry 38 (5), p. 228 - 228 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Kern, N.; Unschuld, P. G.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 38 (5), p. 240 - 240 (2005)

Himmerich, H.; Binder, E. B.; Künzel, H.; Schuld, A.; Lucae, S.; Uhr, M.; Pollmächer, T.; Holsboer, F.; Ising, M.: Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 38 (5), p. 249 - 249 (2005)

Ising, M.; Binder, E. B.; Dose, T.; Horstmann, S.; Kern, N.; Kloiber, S.; Künzel, H. E.; Lucae, S.; Pfennig, A.; Unschuld, P. G. et al.; Modell, S.; Holsboer, F.: Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 38 (5), p. 251 - 251 (2005)

Salyakina, D.; Binder, E. B.; Ising, M.; Uhr, M.; Lucae, S.; Müller-Myhsok, B.: Within- and Inter-gene interactions in FKBP5 and GR genes and its association with early response. Pharmacopsychiatry 38 (5), p. 274 - 274 (2005)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Welt, T.; Kloiber, S.; Kern, N.; Salyakina, D.; Binder, E. B.; Brückl, T. et al.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits. Pharmacopsychiatry 38 (5), p. 282 - 282 (2005)

Wochnik, G. M.; Binder, E. B.; Salyakina, D.; Kohli, M. A.; Kloiber, S.; Holsboer, F.; Rein, T.: The role of FKBP51 in the regulation of the glucocorticoid receptor. Pharmacopsychiatry 38 (5), p. 286 - 286 (2005)

Ising, M.; Künzel, H. E.; Binder, E. B.; Nickel, T.; Modell, S.; Holsboer, F.: The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (6), pp. 1085 - 1093 (2005)

Pfennig, A.; Künzel, H. E.; Kern, N.; Ising, M.; Majer, M.; Fuchs, B.; Ernst, G.; Holsboer, F.; Binder, E. B.: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biological Psychiatry 57 (4), pp. 336 - 342 (2005)

Brunner, J.; Bronisch, T.; Uhr, M.; Ising, M.; Binder, E.; Holsboer, F.; Turck, C. W.: Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. European Archives of Psychiatry and Clinical Neuroscience 255, pp. 438 - 440 (2005)

Post, A.; Ohl, F.; Almeida, O. F. X.; Binder, E. B.; Rücker, M.; Welt, S.; Binder, E.; Holsboer, F.; Sillaber, I.: Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology 180, pp. 150 - 158 (2005)